Public Sector Pension Investment Board Argenx Se Transaction History

Public Sector Pension Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$334.23 - $403.65 $4.13 Million - $4.99 Million	-12,358 Reduced 13.77%	77,375 $28.8 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $2.9 Million - $3.41 Million	-8,467 Reduced 8.62%	89,733 $34 Million
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $14.5 Million - $18 Million	56,300 Added 134.37%	98,200 $29.6 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $11.2 Million - $15.9 Million	41,900 New	41,900 $11.5 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.